The number of contacts with the ombudsman increased 11 percent from 2010 and nearly doubled from the 250 inquiries made in 2009. Nearly two-thirds of the contacts came from within the industry with others coming from consumers (23 percent), healthcare providers (7 percent) and internal employees (5 percent).
Related Articles on the FDA:
FDA Announces 2012 Medical Device Strategic Priorities
FDA Approves Genzyme Framingham Manufacturing Plant
FDA Clears Medtronic’s Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.